The role of HTS in drug discovery at the university of michigan

Martha J. Larsen, Scott D. Larsen, Andrew Fribley, Jolanta Grembecka, Kristoff Homan, Anna Mapp, Andrew Haak, Zaneta Nikolovska-Coleska, Jeanne A. Stuckey, Duxin Sun, David H. Sherman

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

High throughput screening (HTS) is an integral part of a highly collaborative approach to drug discovery at the University of Michigan. The HTS lab is one of four core centers that provide services to identify, produce, screen and follow-up on biomedical targets for faculty. Key features of this system are: protein cloning and purification, protein crystallography, small molecule and siRNA HTS, medicinal chemistry and pharmacokinetics. Therapeutic areas that have been targeted include anti-bacterial, metabolic, neurodegenerative, cardiovascular, anti-cancer and anti-viral. The centers work in a coordinated, interactive environment to affordably provide academic investigators with the technology, informatics and expertise necessary for successful drug discovery. This review provides an overview of these centers at the University of Michigan, along with case examples of successful collaborations with faculty.

Original languageEnglish (US)
Pages (from-to)210-230
Number of pages21
JournalCombinatorial Chemistry and High Throughput Screening
Volume17
Issue number3
DOIs
StatePublished - Mar 2014

Keywords

  • Drug discovery
  • High throughput screening
  • Medicinal chemistry
  • Pharmacokinetics
  • Protein crystallography
  • Structural biology

ASJC Scopus subject areas

  • Drug Discovery
  • Computer Science Applications
  • Organic Chemistry

Fingerprint Dive into the research topics of 'The role of HTS in drug discovery at the university of michigan'. Together they form a unique fingerprint.

Cite this